JP2015519049A5 - - Google Patents

Download PDF

Info

Publication number
JP2015519049A5
JP2015519049A5 JP2015510631A JP2015510631A JP2015519049A5 JP 2015519049 A5 JP2015519049 A5 JP 2015519049A5 JP 2015510631 A JP2015510631 A JP 2015510631A JP 2015510631 A JP2015510631 A JP 2015510631A JP 2015519049 A5 JP2015519049 A5 JP 2015519049A5
Authority
JP
Japan
Prior art keywords
substance
side chain
alicyclic
peptide
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015510631A
Other languages
English (en)
Other versions
JP2015519049A (ja
Filing date
Publication date
Priority claimed from CN2012101483927A external-priority patent/CN103387975A/zh
Application filed filed Critical
Publication of JP2015519049A publication Critical patent/JP2015519049A/ja
Publication of JP2015519049A5 publication Critical patent/JP2015519049A5/ja
Pending legal-status Critical Current

Links

Description

本発明における「環状リポペプチド物質」または「脂環式ペプチド」とは、ポリペプチド環を含有し、この環にある側鎖が「アシルアミノ基」を含有する物質を指すが、この物質はほかの側鎖を有してもよい。
この「環状リポペプチド物質」の代表は、FR901379、echinocandin B(エキノカンジンB)で、このような物質は抗真菌活性を有する既知のものである。
当該発明の固定化脂環式ペプチドアシルトランスフェラーゼは、脂環式ペプチド物質の側鎖の「アミド基」を脱アシル化して「アミノ基」を形成することができ、具体的に、物質FR901379またはその塩のパルミトイル側鎖または物質FR901379を含む、式Iで表される化合物のアシル側鎖を脱アシル化し、式IIで表される脂環式ペプチド物質を得ることができる。
JP2015510631A 2012-05-11 2013-05-10 固定化脂環式ペプチドアシルトランスフェラーゼ及びその製造方法と用途 Pending JP2015519049A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2012101483927A CN103387975A (zh) 2012-05-11 2012-05-11 一种固定化环脂肽酰基转移酶及其制备方法和用途
CN201210148392.7 2012-05-11
PCT/CN2013/075508 WO2013166993A1 (zh) 2012-05-11 2013-05-10 一种固定化环脂肽酰基转移酶及其制备方法和用途

Publications (2)

Publication Number Publication Date
JP2015519049A JP2015519049A (ja) 2015-07-09
JP2015519049A5 true JP2015519049A5 (ja) 2016-06-30

Family

ID=49532397

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015510631A Pending JP2015519049A (ja) 2012-05-11 2013-05-10 固定化脂環式ペプチドアシルトランスフェラーゼ及びその製造方法と用途

Country Status (9)

Country Link
US (2) US20150140604A1 (ja)
EP (1) EP2848685B1 (ja)
JP (1) JP2015519049A (ja)
KR (1) KR20150013726A (ja)
CN (1) CN103387975A (ja)
AU (1) AU2013258683A1 (ja)
CA (1) CA2873090C (ja)
RU (1) RU2014149304A (ja)
WO (1) WO2013166993A1 (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105154424B (zh) * 2015-09-28 2018-10-16 杭州华东医药集团新药研究院有限公司 一种固定化环脂肽脱酰酶的制备方法及其应用
CN115786379A (zh) * 2023-01-06 2023-03-14 成都雅途生物技术有限公司 固定化酶与制备方法以及固定化酶转化fr901379的方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3892580A (en) * 1973-03-26 1975-07-01 Corning Glass Works Method of making porous inorganic bodies
US3930951A (en) 1974-05-28 1976-01-06 Corning Glass Works Bonding enzymes to porous inorganic carriers
JPS5548392A (en) * 1978-02-17 1980-04-07 Toyo Jozo Co Ltd Novel immobilizing material combined with biologically active substance, its preparation, device comprising it, method, and preparation of support
US4288549A (en) 1979-06-08 1981-09-08 Eli Lilly And Company Method of producing the A-30912 antibiotics
US4320053A (en) 1979-12-13 1982-03-16 Eli Lilly And Company Derivatives of A-30912D nucleus
JPS6322802A (ja) * 1987-03-31 1988-01-30 Toyo Jozo Co Ltd 新規なアミノ化アクリロニトリル系ポリマ−の製造法
DE3880273T2 (de) * 1987-11-27 1993-07-29 Ecc Int Ltd Poroese anorganische materialien.
GB8925593D0 (en) 1989-11-13 1990-01-04 Fujisawa Pharmaceutical Co Fr901379 substance and preparation thereof
FI912873A (fi) * 1990-06-18 1991-12-19 Fujisawa Pharmaceutical Co Ny polypeptidfoerening och foerfarande foer dess framstaellning.
DE69739532D1 (de) * 1996-03-08 2009-09-24 Astellas Pharma Inc Prozess für die deacylierung von zyklischen lipopeptiden.
WO1997047738A1 (fr) 1996-06-13 1997-12-18 Fujisawa Pharmaceutical Co., Ltd. Acylase des lipopeptides cycliques
BR122016015076B1 (pt) * 2003-01-17 2017-05-16 Dupont Nutrition Biosci Aps método de produção de um éster de carboidrato e uso de uma enzima lipídio aciltransferase para produzir um éster de carboidrato
US7378261B2 (en) * 2003-04-14 2008-05-27 E.I. Du Pont De Nemours And Company Method for preparing para-hydroxystyrene by biocatalytic decarboxylation of para-hydroxycinnamic acid in a biphasic reaction medium
US9303256B2 (en) 2005-09-30 2016-04-05 Novozymes A/S Immobilization of enzymes
EP2592140A4 (en) * 2010-06-09 2014-08-13 Jgc Corp SUPPORT FOR IMMOBILIZATION OF A PROTEIN, IMMOBILIZED PROTEIN AND PRODUCTION METHOD THEREOF
US8877777B2 (en) * 2010-09-30 2014-11-04 Shanghai Techwell Biopharmaceutical Co., Ltd. Process for purifying cyclolipopeptide compounds or the salts thereof

Similar Documents

Publication Publication Date Title
HRP20191254T1 (hr) Peptidi koji prodiru u stanice i postupci za njihovu proizvodnju i uporabu
EA201790378A1 (ru) Заключенное в липосому аффинное лекарственное средство
UA118167C2 (uk) Пептид та його застосування
PT3656782T (pt) Composto amida peptídica e o seu método de preparação e utilização médica
MA41294A (fr) Anticorps anti-myostatine, polypeptides contenant des variants de régions fc, et procédés d'utilisation
WO2014139476A8 (zh) Rsv融合蛋白的表位以及识别其的抗体
WO2015013330A3 (en) Ophthalmic uses of toxin-based therapeutic peptides and pharmaceutical compositions thereof
WO2017032856A3 (en) Compounds for inducing tissue formation and uses thereof
IL290414A (en) atf5 peptide variants and uses thereof
MA43685A (fr) Solutions aqueuses d'acides aminés n-acylés
GB2517354A (en) Hydrochloride salt of peptide and its use in combination with other peptides for immunotherapy
NZ718534A (en) Novel peptides and analogs for use in the treatment of oral mucositis
SG11202000801QA (en) Highly versatile method of presenting cyclic peptide on protein structure
MA49564A (fr) Modulateurs thérapeutiques du mode inverse de l'atp synthase
WO2015043566A8 (de) Zyklische, amyloid-beta-bindende peptide und deren verwendung
JP2015519049A5 (ja)
HRP20190449T1 (hr) Hidrobromidna sol n-(4-klor-2-hidroksi-3-((3s)-3-piperidinilsulfonil)fenil)-n’-(3-fluor-2-metilfenil)uree
WO2017032853A3 (en) Compounds for inducing tissue formation and uses thereof
MX2015002279A (es) Peptido pntx(19) sintético, composición farmacéutica.y uso.
WO2016090163A3 (en) Anti-acetaminophen antibodies and acetaminophen protein adducts
JP2017517561A5 (ja)
RU2013119051A (ru) Тетрапептид и средство, обладающее церебропротекторной и антиамнестической активностями
EP2593546A4 (en) AFFINITY CLEANING OF RNA UNDER NATIVE CONDITIONS BASED ON LAMBDA BOX B / N PEPTIDE INTERACTION
IL280931A (en) Collections of peptides, peptide materials, and methods of using them
EA201592019A1 (ru) Лиофилизат, содержащий циклический пептид формулы x-gqretpegaeakpwy-x